By Business/Source
Currency:USD
2025/FY
Stock NameRevenueRatio
Life Sciences Services102.15M57.98%
Life Sciences Products75.77M43.01%
Elimination of intersegment revenue-1.74M-0.99%
By Country/Region
Currency:USD
2025/FY
Stock NameRevenueRatio
Americas131.26M74.50%
Europe, the Middle East, and Africa (EMEA)25.13M14.27%
Asia-Pacific (APAC)19.78M11.23%